Self-Test for the detection of Follicle Stimulating Hormone – FSH in urine
MENOPAUSE & FSH
Menopause is a physiological event caused by a change in women’s hormonal balance. We talk abouy “menopause” when at least 12 consecutive months have elapsed in the absence of menstruation.
The irregularity of menstrual cycles can therefore be a first indicator of the onset of menopause, or rather of the so-called “perimenopause”. Menopause is the consequence of the depletion of ovarian follicles leading to increased levels of circulating follicle stimulating hormone (FSH). FSH concentrations increase in menopause from values below 20 mUI/mL to values up to approximately 80 mUI/mL.
WHO IS THIS TEST FOR?
MENOPAUSE FSH TEST is indicated for women who begin to experience symptoms related to menopause: lack of menstrual cycles, hot flashes, sleep irregularities and obvious mood changes.
The change in hormonal balance associated with the onset of menopause generally occurs around age 45, although the real signs appear around age 55.
MENOPAUSE FSH TEST is an immunochromatographic device that detects the FSH hormone in urine thanks to special gold-conjugated monoclonal antibodies incorporated in the test strip.
2 spoon devices
instructions for use
Remove the protective cap and place the absorbing tip right under the flow of urine for at least 10 seconds;
Alternatively, collect the urine in a clean and dry container and dip the absorbing tip into the urine for 10 seconds;
Place the protective cap back onto the spoon device and wait 5 minutes before reading the result.
FSH levels are below the cut-off. This indicates that the menopause process has probably not started yet.
FSH concentration in urine is equal to or greater than 25mUI/mL. Repeat the test after 5-7 days, as FSH levels can vary throughout the month. In case of confirmation of positivity, consult a specialist.
1. Robert J. Norman “Fertility testing” Australian Prescriber, 2002;25:38-401
2. Buckler H. “The menopause transition: endocrine changes and clinical symptoms.” J Br Menopause Soc. 2005 Jun;11(2):61-5.
3. National Collaborating Centre for Women’s and Children’s Health (UK) “Menopause: Full Guideline”. 2015 Nov. National Institute for Health and Care Excellence: Clinical Guidelines.
The test has been carried out correctly when the instructions for use are followed. It includes the reading time and the interpretation of the results shown at the "RESULTS INTERPRETATION" section of the instructions for use.
A colored line will appear at the control region (C) on the test device, showing that the test performed correctly. The absence of the colored line suggests to repeat the test with a new device and a new sample.
Utilizziamo cookie e tecnologie di tracciamento simili per tracciare l’attività sul nostro Servizio e conservare determinate informazioni.
I cookie sono token, o piccoli pacchetti di dati, che possono includere un identificatore univoco anonimo. I cookie vengono inviati al tuo browser da un sito web e memorizzati sul tuo dispositivo. Le tecnologie di monitoraggio utilizzate sono anche beacon, tag e script per raccogliere e tenere traccia delle informazioni e per migliorare e analizzare il nostro Servizio.
Puoi chiedere al tuo browser di rifiutare tutti i cookie o di indicare quando viene inviato un cookie. Tuttavia, se non si accettano i cookie, potrebbe non essere possibile utilizzare alcune parti del nostro Servizio.